Fixed Price IPO | ₹13 Cr | Listed at NSE SME | Mon, Jan 16, 2023 - Thu, Jan 19, 2023
Aristo Bio-Tech IPO is a fixed price issue of ₹13.05 crores. The issue is entirely a fresh issue of 0.18 crore shares of ₹13.05 crore.
Aristo Bio-Tech IPO bidding started from Jan 16, 2023 and ended on Jan 19, 2023. The allotment for Aristo Bio-Tech IPO was finalized on Jan 24, 2023. The shares got listed on NSE SME on Jan 30, 2023.
Aristo Bio-Tech IPO price is ₹72 per share. The lot size for an application is 1,600. The minimum amount of investment required by an individual investor (retail) is ₹1,15,200 (1600 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (3,200 shares), amounting to ₹2,30,400.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Sunflower Broking Pvt.Ltd..
Refer to Aristo Bio-Tech IPO RHP for detailed Information.
IPO Open
Mon, Jan 16, 2023
IPO Close
Thu, Jan 19, 2023
Issue Price
₹72 per share
Market Cap (Pre-IPO)
₹49.02 Cr
| IPO Date | 16 to 19 Jan, 2023 |
| Listed on | Mon, Jan 30, 2023 |
| Face Value | ₹10 per share |
| Issue Price | ₹72 per share |
| Lot Size | 1,600 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Total Issue Size | 18,12,800 shares (agg. up to ₹13 Cr) |
| Reserved for Market Maker | 91,200 shares Sunflower Broking Pvt.Ltd. (agg. up to ₹0.6566 Cr) |
| Fresh Issue (Ex Market Maker) | 17,21,600 shares (agg. up to ₹12 Cr) |
| Net Offered to Public | 17,21,600 shares (agg. up to ₹12 Cr) |
| Share Holding Pre Issue | 49,95,000 shares |
| Share Holding Post Issue | 68,07,800 shares |
| NSE Symbol | ARISTO |
| ISIN | INE082101010 |
Aristo Bio-Tech IPO comprises a total issue size of 18,12,800 shares. The net offer to the public is 17,21,600 shares, after excluding 91,200 shares allotted on a firm basis. Of the Net offer 8,60,800 (50.00%) allocated to NII 8,60,800 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 8,60,800 | 50.00% | 47.48% |
| Retail Shares Offered | 8,60,800 | 50.00% | 47.48% |
| Firm Reservations | |||
| Market Maker Shares Offered | 91,200 | 5.03% | |
| Total Shares Offered | 18,12,800 | 100.00% | 100.00% |
Investors can bid for a minimum of 1,600 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,15,200 |
| Retail (Max) | 1 | 1,600 | ₹1,15,200 |
| HNI (Min) | 2 | 3,200 | ₹2,30,400 |
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
They deliver their products in India as well as engage in exporting products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.
The industry Aristo Bio-Tech and Lifescience is engaged in, is full of possibilities where the entities deal in the production and distribution of pesticides and fertilizers. All these entities contribute towards enhancing crop yields and their quality.
Aristo Bio-Tech and Lifescience are delivering their products in over 20 states of India. Also, the offerings are extended to over 15 countries, including Armenia, Australia, Bangladesh, Belgium, Cambodia, Germany, Italy, Kenya, Moldova, New Zealand, Poland, South Africa, UAE, Ukraine, and Vietnam.
The company is ISO 9001: 2015 certified for their Quality Management System. Following are the products of Aristo:
Alongside undertaking manufacturing operations, the company also provide Contract manufacturing, Job work and Toll manufacturing services for Crop Protection companies.
| Period Ended | 30 Sep 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|
| Assets | 108.69 | 77.00 | 81.42 | 87.85 |
| Total Income | 129.07 | 166.03 | 167.23 | 201.24 |
| Profit After Tax | 2.59 | 1.46 | 1.08 | 1.01 |
| NET Worth | 17.43 | 14.84 | 13.38 | 12.31 |
| Reserves and Surplus | 12.44 | 9.85 | 8.39 | 7.31 |
| Total Borrowing | 29.36 | 25.48 | 22.25 | 19.71 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Meet Working Capital Requirement | 9.35 |
| 2 | General Corporate Expenses | 2.50 |
| 3 | Public Issue Expenses | 1.20 |
| KPI | |
|---|---|
| ROE | 29.26 |
| ROCE | 35.64 |
| Debt/Equity | 5.10 |
| RoNW | 10 |
| PAT Margin | 0.88% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 2.93 | |
| P/E (x) | 9.46 | |
| Promoter Holding | 100.00% | 73.37% |
| Market Cap | ₹49.02 Cr. |
The Aristo Bio-Tech and Lifescience IPO is subscribed 217.72 times on January 19, 2023 7:00:00 PM (Day 4). The public issue subscribed 149.59 times in the retail category, [.] times in the QIB category, and 285.84 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| NII* | 285.84 | 8,60,800 | 24,60,52,800 |
| Retail | 149.59 | 8,60,800 | 12,87,71,200 |
| Total | 217.72 | 17,21,600 | 37,48,24,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manager Fees including underwriting commission | 0.93 |
| 2 | Brokerage, selling, commission and upload fees | 0.01 |
| 3 | Registrar to the issue | 0.01 |
| 4 | Legal Advisors | 0.01 |
| 5 | Advertising and Marketing expenses | 0.05 |
| 6 | Regulators including stock exchanges | 0.05 |
| 7 | Printing and distribution of issue stationery | 0.02 |
| 8 | Others, if any (market making, depositories, secretarial, peer review auditors, etc.) | 0.12 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹72.00 |
| Open | ₹80.00 |
| Low | ₹76.05 |
| High | ₹84.00 |
| Last Trade | ₹84.00 |
Lead Manager Reports
Aristo Bio-Tech IPO is a SME IPO of 18,12,800 equity shares of the face value of ₹10 aggregating up to ₹13 Crores. The issue is priced at ₹72 per share. The minimum order quantity is 1600.
The IPO opens on Mon, Jan 16, 2023, and closes on Thu, Jan 19, 2023.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Aristo Bio-Tech IPO using UPI as a payment gateway. Zerodha customers can apply in Aristo Bio-Tech IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Aristo Bio-Tech IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Aristo Bio-Tech IPO opens on Mon, Jan 16, 2023 and closes on Thu, Jan 19, 2023.
Aristo Bio-Tech IPO lot size is 1600, and the minimum amount required for application is ₹1,15,200.
You can apply in Aristo Bio-Tech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Aristo Bio-Tech IPO will be done on Tuesday, January 24, 2023, and the allotted shares will be credited to your demat account by Fri, Jan 27, 2023. Check the Aristo Bio-Tech IPO allotment status.
The Aristo Bio-Tech IPO listing date is on Mon, Jan 30, 2023.
